Health Challenges Congress
On 7-8 March, the IV Health Challenges Congress (HCC) will take place at the International Congress Center in Katowice. Magdalena Władysiuk...
HTA Consulting is a Polish company with long-time experience, specialising in health technology assessment for drugs, medical devices and diagnostic methods in Poland and worldwide. We analyse, advise and train in the field of legislative and systemic solutions, pricing, designing and implementing research for health care organisations and private institutions.
What is
OUR MISSION
It is our mission to seek the truth using scientific research methods. With our experience and know-how we support taking rational and evidence-based decisions in health care. We do not engage in, have not engaged in nor do we intend to engage in any activities related to lobbying in favour of or against any company manufacturing medicinal products, medical devices or medical supplies.
We Have
THE STORY BEHIND OUR COMPANY
HTA Consulting was established in 2001 in Krakow and pioneers in health technology assessment studies both in Poland and in Central and Eastern Europe. At present the primary activity of HTA Consulting is conducting assessments of safety, efficacy and costs of alternative treatment options in line with best credibility criteria adopted worldwide, i.e. Evidence-Based Health Care... [ read more ]
500
HTA REPORTS
70
CLIENTS ALL OVER THE WORLD
15
YEARS OF EXPERIENCE
Our Offer
HTA Consulting is an expertise company with extensive experience and proven credibility in health technology assessment. It is regarded as a trusted partner for many worldwide health care companies expecting high quality analysis and strategic advisory with a rational assessment of the opportunities offered by the product. The unique team of interdisciplinary experts connecting scientific approach and business spirit stays at the core of the company’s success.
Latest News
February 26, 2019
February 21, 2019Adalimumab – official price, limit, real price (data from NHF – DGL) per 1 mg
2 of brands of adalimumab (Humira and Imraldi) are reimbursement in Poland under 5 drug programmes. Since the start of reimbursement i...
February 14, 2019Renegotiations 2018/2019 – Outpatient list
HTA Consulting studied the impact of renegotiations between pharmaceutical companies and the Ministry of Health due to expiry of temporal de...
February 1, 2019“Proposal for a Regulation on Health Technology Assessment in Europe…”
An article ‘Proposal for a Regulation on Health Technology Assessment in Europe – opinions of policy makers, payers and academics ...
Our Partners
Contact
If you have any question, do not hesitate to ask our representatives.
ul. Starowiślna 17/3
31-038 Kraków, POLAND
phone (+48) 12 421 88 32
mobile (+48) 508 180 859
fax (+48) 12 395 38 32
NIP 675-12-67-600